FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Karen Reckamp

Research Profile

Disorders

Chemicals & Drugs

Procedures

Co-author Network

Publications

TOP 3
Marianna Koczywas; Karen Reckamp; Brian L Tiep; Gwen C Uman; Anna Cathy Williams; Mihaela Cristea; Frederic W Grannis; Betty Ferrell
Longitudinal changes in function, symptom burden, and quality of life in patients with early-stage lung cancer.
Karen Reckamp
Phosphatidylinositol-3-kinase pathway.
Andrea A Thornton; Mihaela Cristea; Frederic Grannis; Kemp Kernstine; Marianna Koczywas; Jason E Owen; Karen Reckamp; Annette L Stanton
Predictors of finding benefit after lung cancer diagnosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Karen Reckamp (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Marianna Koczywas; Karen Reckamp; Brian L Tiep; Gwen C Uman; Anna Cathy Williams; Mihaela Cristea; Frederic W Grannis; Betty Ferrell
Longitudinal changes in function, symptom burden, and quality of life in patients with early-stage lung cancer.
Annals of surgical oncology 2013;20(6):1788-97.
2012: Karen Reckamp
Phosphatidylinositol-3-kinase pathway.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(16 Suppl 5):S383-4.
2012: Andrea A Thornton; Mihaela Cristea; Frederic Grannis; Kemp Kernstine; Marianna Koczywas; Jason E Owen; Karen Reckamp; Annette L Stanton
Predictors of finding benefit after lung cancer diagnosis.
Psycho-oncology 2012;21(4):365-73.
2012: J Portnow; Karen Reckamp; Stephen Shibata; Przemyslaw Twardowski; Warren Chow; V Chung; M Cristea; Paul Frankel; S Koehler; Lucille Leong; Dean Lim; C Martel; R Morgan; Timothy W Synold
A phase I study of bortezomib and temozolomide in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2012;69(2):505-14.
2011: Karen Reckamp
Novel mechanisms and targets: miscellaneous agents.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(11 Suppl 4):S1812-4.
2011: Hong Xin; Chunyan Zhang; Wang Zhang; Michael Zinda; Zhu A Cao; Robert Figlin; Michael Hedvat; Andreas Herrmann; Dennis Huszar; Richard Jove; Wei Liang; Deborah Morosini; Sumanta Pal; Karen Reckamp; Anna Scuto; Shaobu Weng; Hua Yu
Antiangiogenic and antimetastatic activity of JAK inhibitor AZD1480.
Cancer research 2011;71(21):6601-10.
2011: Suresh S Ramalingam; Karen Reckamp; Ravi Salgia; Miguel Villalona-Calero; Everett E Vokes; John J Wright; Chandra P Belani; Angela M Davies; Martin J Edelman; Barbara Gitlitz; Primo Lara; Jeffrey Longmate; David R Gandara
Bortezomib for patients with advanced-stage bronchioloalveolar carcinoma: a California Cancer Consortium Phase II study (NCI 7003).
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(10):1741-5.
2011: G R Blumenschein; Y-J Hei; Fairooz Kabbinavar; K Kracht; K Lakshmaiah; H Menon; Tony Shu Kam Mok; Karen Reckamp; L Schwartzberg; R Sikorski; J Stephenson; Y-N Sun; J T Beck
A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(9):2057-67.
2011: Ari VanderWalde; Sumanta Kumar Pal; Karen Reckamp
Management of non-small-cell lung cancer in the older adult.
Maturitas 2011;68(4):311-21.
2011: Karen Reckamp; Barbara Gitlitz; Lin-Chi Chen; Ravi Patel; Ginger Milne; Mary Syto; Deborah Jezior; Sara Zaknoen
Biomarker-based phase I dose-escalation, pharmacokinetic, and pharmacodynamic study of oral apricoxib in combination with erlotinib in advanced nonsmall cell lung cancer.
Cancer 2011;117(4):809-18.
2011: Amrita Krishnan; Karen Reckamp; Lucille Leong
City of Hope Cancer Center hematology-oncology fellowship and hematopoietic stem cell transplantation fellowship.
American journal of hematology 2011;86(2):197-8.
2011: Primo Lara; Jeff Longmate; Karen Reckamp; Barbara Gitlitz; Athanassios Argiris; Suresh Ramalingam; Chandra P Belani; Philip C Mack; Derick H Lau; Mariana Koczywas; John J Wright; Frances A Shepherd; Natasha B Leighl; David R Gandara
Randomized phase II trial of concurrent versus sequential bortezomib plus docetaxel in advanced non-small-cell lung cancer: a California cancer consortium trial.
Clinical lung cancer 2011;12(1):33-7.
2011: Heehyoung Lee; Sumanta Kumar Pal; Karen Reckamp; Robert A Figlin; Hua Yu
STAT3: a target to enhance antitumor immune response.
Current topics in microbiology and immunology 2011;344():41-59.
2010: Maciej Kujawski; Chunyan Zhang; Andreas Herrmann; Karen Reckamp; Anna Scuto; Michael Jensen; Jiehui Deng; Stephen Forman; Robert Figlin; Hua Yu
Targeting STAT3 in adoptively transferred T cells promotes their in vivo expansion and antitumor effects.
Cancer research 2010;70(23):9599-610.
2010: Sumanta K Pal; Karen Reckamp
Mammalian target of rapamycin, Akt, and phosphatidylinositol 3-kinase signaling.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(12 Suppl 6):S487-9.
2010: Sumanta Kumar Pal; Karen Reckamp; Hua Yu; Robert A Figlin
Akt inhibitors in clinical development for the treatment of cancer.
Expert opinion on investigational drugs 2010;19(11):1355-66.
2010: Andreas Herrmann; Marcin Kortylewski; Maciej Kujawski; Chunyan Zhang; Karen Reckamp; Brian Armstrong; Lin Wang; Claudia M Kowolik; Jiehui Deng; Robert Figlin; Hua Yu
Targeting Stat3 in the myeloid compartment drastically improves the in vivo antitumor functions of adoptively transferred T cells.
Cancer research 2010;70(19):7455-64.
2010: Cedric Wiesner; Charles Hannum; Karen Reckamp; Robert Figlin; Robert Dubridge; Sushmita Mimi Roy; Shanhua Lin; Christopher H Becker; Ted Jones; Jordan Hiller; John C Cheville; Keith Wilson
Consistency of a two clinical site sample collection: a proteomics study.
Proteomics. Clinical applications 2010;4(8-9):726-38.
2010: Sumanta Kumar Pal; Robert A Figlin; Karen Reckamp
Targeted therapies for non-small cell lung cancer: an evolving landscape.
Molecular cancer therapeutics 2010;9(7):1931-44.
2010: Eric Haura; D Ross Camidge; Karen Reckamp; Alberto Chiappori; Faye Johnson; Roy Herbst; Kwok Wong; David Carbone
Molecular origins of lung cancer: prospects for personalized prevention and therapy.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(6 Suppl 3):S207-13.
2010: Felicita Baratelli; Jay M Lee; Saswati Hazra; Ying Lin; Tonya C Walser; Dorthe Schaue; Peter S Pak; David Elashoff; Karen Reckamp; Ling Zhang; Michael C Fishbein; Sherven Sharma; Steven M Dubinett
PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancer.
American journal of translational research 2010;2(4):356-67.
2010: George R Blumenschein; Karen Reckamp; G Joe Stephenson; Timothy O'Rourke; Gregory W Gladish; Jesse McGreivy; Yu-Nien Sun; Yining Ye; Mandy Parson; Alan B Sandler
Phase 1b study of motesanib, an oral angiogenesis inhibitor, in combination with carboplatin/paclitaxel and/or panitumumab for the treatment of advanced non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(1):279-90.
2009: Chris Planque; Vathany Kulasingam; Chris R Smith; Karen Reckamp; Lee Goodglick; Eleftherios P Diamandis
Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines.
Molecular & cellular proteomics : MCP 2009;8(12):2746-58.
2009: Ross Camidge; Laurie Gaspar; Glennwood Goss; Karen Kelly; Suresh Ramalingam; Karen Reckamp; George Simon; Ming Tsao; Howard Jack West; Roy Herbst; David Johnson; Paul Bunn; Ramaswamy Govindan
Summary of selected presentations from the 8th annual targeted therapy in lung cancer symposium.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(7):930-5.
2009: Karen Reckamp; Robert A Figlin; Marie D Burdick; Steven M Dubinett; Robert M Elashoff; Robert M Strieter
CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer.
BMC cancer 2009;9():213.
2008: Robert A Figlin; Elizabeth Brown; Andrew J Armstrong; Wallace Akerley; Al B Benson; Harold J Burstein; David S Ettinger; Phillip G Febbo; Matthew G Fury; Gary R Hudes; Merrill S Kies; Eunice L Kwak; Robert J Morgan; Joanne Mortimer; Karen Reckamp; Alan P Venook; Frank Worden; Yun Yen
NCCN Task Force Report: mTOR inhibition in solid tumors.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6 Suppl 5():S1-20; quiz S21-2.
2008: Karen Reckamp; Robert M Strieter; Robert A Figlin
Chemokines as therapeutic targets in renal cell carcinoma.
Expert review of anticancer therapy 2008;8(6):887-93.
2008: Chris Planque; Lin Li; Yingye Zheng; Antoninus Soosaipillai; Karen Reckamp; David Chia; Eleftherios P Diamandis; Lee Goodglick
A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(5):1355-62.
2008: Karen Reckamp; Brian Gardner; Robert A Figlin; David Elashoff; Kostyantyn Krysan; Mariam Dohadwala; Jenny Mao; Sherven Sharma; Landon Inge; Ayyappan Rajasekaran; Steven M Dubinett
Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(2):117-24.
2008: Kostyantyn Krysan; Jay M Lee; Mariam Dohadwala; Brian Gardner; Karen Reckamp; Edward Garon; Maie St John; Sherven Sharma; Steven M Dubinett
Inflammation, epithelial to mesenchymal transition, and epidermal growth factor receptor tyrosine kinase inhibitor resistance.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(2):107-10.
2007: Katherine A Peebles; Jay M Lee; Jenny T Mao; Saswati Hazra; Karen Reckamp; Kostyantyn Krysan; Mariam Dohadwala; Eileen L Heinrich; Tonya C Walser; Xiaoyan Cui; Felicita Baratelli; Edward Garon; Sherven Sharma; Steven M Dubinett
Inflammation and lung carcinogenesis: applying findings in prevention and treatment.
Expert review of anticancer therapy 2007;7(10):1405-21.
2007: Karen Reckamp; Robert A Figlin; Nancy Moldawer; Allan J Pantuck; Arie S Belldegrun; Marie D Burdick; Robert M Strieter
Expression of CXCR3 on mononuclear cells and CXCR3 ligands in patients with metastatic renal cell carcinoma in response to systemic IL-2 therapy.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2007;30(4):417-24.
2006: Karen Reckamp; Kostyantyn Krysan; Jason D Morrow; Ginger L Milne; Robert A Newman; Christopher Tucker; Robert M Elashoff; Steven M Dubinett; Robert A Figlin
A phase I trial to determine the optimal biological dose of celecoxib when combined with erlotinib in advanced non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(11 Pt 1):3381-8.
2006: Kostyantyn Krysan; Karen Reckamp; Sherven Sharma; Steven M Dubinett
The potential and rationale for COX-2 inhibitors in lung cancer.
Anti-cancer agents in medicinal chemistry 2006;6(3):209-20.
2006: Seok-Chul Yang; Raj K Batra; Sven Hillinger; Karen Reckamp; Robert M Strieter; Steven M Dubinett; Sherven Sharma
Intrapulmonary administration of CCL21 gene-modified dendritic cells reduces tumor burden in spontaneous murine bronchoalveolar cell carcinoma.
Cancer research 2006;66(6):3205-13.
2006: Judong Pan; Javier Mestas; Marie D Burdick; Roderick J Phillips; George V Thomas; Karen Reckamp; John A Belperio; Robert M Strieter
Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis.
Molecular cancer 2006;5():56.
2005: Javier Mestas; Marie D Burdick; Karen Reckamp; Allan J Pantuck; Robert A Figlin; Robert M Strieter
The role of CXCR2/CXCR2 ligand biological axis in renal cell carcinoma.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(8):5351-7.
2005: Robert Suh; Karen Reckamp; Michelle Zeidler; Robert Cameron
Radiofrequency ablation in lung cancer: promising results in safety and efficacy.
Oncology (Williston Park, N.Y.) 2005;19(11 Suppl 4):12-21.
2005: Felicita Baratelli; Ying Lin; Li Zhu; Seok-Chul Yang; Nathalie Heuzé-Vourc'h; Gang Zeng; Karen Reckamp; Mariam Dohadwala; Sherven Sharma; Steven M Dubinett
Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(3):1483-90.
2005: Felicita Baratelli; Kostyantyn Krysan; Nathalie Heuzé-Vourc'h; Li Zhu; Brian Escuadro; Sherven Sharma; Karen Reckamp; Mariam Dohadwala; Steven M Dubinett
PGE2 confers survivin-dependent apoptosis resistance in human monocyte-derived dendritic cells.
Journal of leukocyte biology 2005;78(2):555-64.
2005: Kostyantyn Krysan; Karen Reckamp; Harnisha Dalwadi; Sherven Sharma; Enrique Rozengurt; Mariam Dohadwala; Steven M Dubinett
Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.
Cancer research 2005;65(14):6275-81.
2005: Sherven Sharma; Li Zhu; Seok-Chul Yang; Ling Zhang; Jeff Lin; Sven Hillinger; Brian Gardner; Karen Reckamp; Robert M Strieter; Min Huang; Raj K Batra; Steven M Dubinett
Cyclooxygenase 2 inhibition promotes IFN-gamma-dependent enhancement of antitumor responses.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(2):813-9.
2005: Jenny T Mao; Xiaoyan Cui; Karen Reckamp; Ming Liu; Kostyantyn Krysan; Harnisha Dalwadi; Sherven Sharma; Saswati Hazra; Robert M Strieter; Brian Gardner; Steven M Dubinett
Chemoprevention strategies with cyclooxygenase-2 inhibitors for lung cancer.
Clinical lung cancer 2005;7(1):30-9.
2005: Sherven Sharma; Seok-Chul Yang; Li Zhu; Karen Reckamp; Brian Gardner; Felicita Baratelli; Min Huang; Raj K Batra; Steven M Dubinett
Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer.
Cancer research 2005;65(12):5211-20.